Lung Non-Squamous Non-Small Cell Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

408 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 93
Recruiting: 47
Ph III recruiting: 15
Growth YoY: —
Industry share: 39%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (55)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02475382	Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen(CheckMate 169)	no longer available	—	—	Bristol-Myers SquibbINDUSTRY	2	Nov 27, 2020	clinicaltrials

Data updated 22 days agoSource updated Nov 27, 2020source: clinicaltrials